Trial Profile
Alemtuzumab Induction in Lung Transplantation: Efficacy and Safety
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Antithymocyte globulin; Corticosteroids; Immunosuppressants; Mycophenolate mofetil
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 10 May 2012 New trial record